Zhang Li, Xu Jing, Qi Xiaoling, Tao Zheying, Yang Zhitao, Chen Wei, Wang Xiaoli, Pan Tingting, Dai Yunqi, Tian Rui, Chen Yang, Tang Bin, Liu Zhaojun, Tan Ruoming, Qu Hongping, Yu Yue, Liu Jialin
Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Emergency Department, Ruijin Hospital affiliate to Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
Infect Drug Resist. 2022 May 2;15:2371-2381. doi: 10.2147/IDR.S348278. eCollection 2022.
Since the outbreak of coronavirus disease (COVID-19) in December 2019 in Wuhan, it has spread rapidly worldwide. We aimed to establish and validate a nomogram that predicts the probability of coronavirus-associated acute respiratory distress syndrome (CARDS).
In this single-centre, retrospective study, 261 patients with COVID-19 were recruited using positive reverse transcription-polymerase chain reaction tests for severe acute respiratory syndrome coronavirus 2 in Tongji Hospital at Huazhong University of Science and Technology (Wuhan, China). These patients were randomly distributed into the training cohort (75%) and the validation cohort (25%). The factors included in the nomogram were determined using univariate and multivariate logistic regression analyses based on the training cohort. The area under the receiver operating characteristic curve (AUC), consistency index (C-index), calibration curve, and decision curve analysis (DCA) were used to evaluate the efficiency of the nomogram in the training and validation cohorts.
Independent predictive factors, including fasting plasma glucose, platelet, D-dimer, and cTnI, were determined using the nomogram. In the training cohort, the AUC and concordance index were 0.93. Similarly, in the validation cohort, the nomogram still showed great distinction (AUC: 0.92) and better calibration. The calibration plot also showed a high degree of agreement between the predicted and actual probabilities of CARDS. In addition, the DCA proved that the nomogram was clinically beneficial.
Based on the results of laboratory tests, we established a predictive model for acute respiratory distress syndrome in patients with COVID-19. This model shows good performance and can be used clinically to identify CARDS early.
Ethics committee of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (No.:(2020) Linlun-34th).
自2019年12月新型冠状病毒肺炎(COVID-19)在武汉爆发以来,它已在全球迅速传播。我们旨在建立并验证一种预测冠状病毒相关急性呼吸窘迫综合征(CARDS)发生概率的列线图。
在这项单中心回顾性研究中,采用针对严重急性呼吸综合征冠状病毒2的阳性逆转录聚合酶链反应检测,在中国华中科技大学同济医院(武汉)招募了261例COVID-19患者。这些患者被随机分为训练队列(75%)和验证队列(25%)。基于训练队列,通过单因素和多因素逻辑回归分析确定列线图中包含的因素。采用受试者操作特征曲线下面积(AUC)、一致性指数(C指数)、校准曲线和决策曲线分析(DCA)来评估列线图在训练队列和验证队列中的效能。
使用列线图确定了包括空腹血糖、血小板、D-二聚体和肌钙蛋白I在内的独立预测因素。在训练队列中,AUC和一致性指数为0.93。同样,在验证队列中,列线图仍显示出良好的区分度(AUC:0.92)和更好的校准。校准图还显示了CARDS预测概率与实际概率之间的高度一致性。此外,DCA证明列线图具有临床益处。
基于实验室检测结果,我们建立了COVID-19患者急性呼吸窘迫综合征的预测模型。该模型表现良好,可在临床上用于早期识别CARDS。
上海交通大学医学院附属瑞金医院伦理委员会(编号:(2020)临伦-第34号)